Global Adipose Tissue-derived Stem Cell Therapy Market Growth (Status and Outlook) 2023-2028

Report ID: 1269909 | Published Date: Jan 2025 | No. of Page: 114 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Adipose Tissue-derived Stem Cell Therapy Market Size 2017-2028
        2.1.2 Adipose Tissue-derived Stem Cell Therapy Market Size CAGR by Region 2017 VS 2022 VS 2028
    2.2 Adipose Tissue-derived Stem Cell Therapy Segment by Type
        2.2.1 Autologous Stem Cells
        2.2.2 Allogeneic Stem Cells
    2.3 Adipose Tissue-derived Stem Cell Therapy Market Size by Type
        2.3.1 Adipose Tissue-derived Stem Cell Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028)
        2.3.2 Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type (2017-2022)
    2.4 Adipose Tissue-derived Stem Cell Therapy Segment by Application
        2.4.1 Therapeutic Application
        2.4.2 Research Application
    2.5 Adipose Tissue-derived Stem Cell Therapy Market Size by Application
        2.5.1 Adipose Tissue-derived Stem Cell Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028)
        2.5.2 Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application (2017-2022)
3 Adipose Tissue-derived Stem Cell Therapy Market Size by Player
    3.1 Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Players
        3.1.1 Global Adipose Tissue-derived Stem Cell Therapy Revenue by Players (2020-2022)
        3.1.2 Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Players (2020-2022)
    3.2 Global Adipose Tissue-derived Stem Cell Therapy Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion
4 Adipose Tissue-derived Stem Cell Therapy by Regions
    4.1 Adipose Tissue-derived Stem Cell Therapy Market Size by Regions (2017-2022)
    4.2 Americas Adipose Tissue-derived Stem Cell Therapy Market Size Growth (2017-2022)
    4.3 APAC Adipose Tissue-derived Stem Cell Therapy Market Size Growth (2017-2022)
    4.4 Europe Adipose Tissue-derived Stem Cell Therapy Market Size Growth (2017-2022)
    4.5 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size Growth (2017-2022)
5 Americas
    5.1 Americas Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2017-2022)
    5.2 Americas Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2017-2022)
    5.3 Americas Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2017-2022)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Adipose Tissue-derived Stem Cell Therapy Market Size by Region (2017-2022)
    6.2 APAC Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2017-2022)
    6.3 APAC Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2017-2022)
    6.4 China
    6.5 Japan
    6.6 Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
7 Europe
    7.1 Europe Adipose Tissue-derived Stem Cell Therapy by Country (2017-2022)
    7.2 Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2017-2022)
    7.3 Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2017-2022)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy by Region (2017-2022)
    8.2 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2017-2022)
    8.3 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2017-2022)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Global Adipose Tissue-derived Stem Cell Therapy Market Forecast
    10.1 Global Adipose Tissue-derived Stem Cell Therapy Forecast by Regions (2023-2028)
        10.1.1 Global Adipose Tissue-derived Stem Cell Therapy Forecast by Regions (2023-2028)
        10.1.2 Americas Adipose Tissue-derived Stem Cell Therapy Forecast
        10.1.3 APAC Adipose Tissue-derived Stem Cell Therapy Forecast
        10.1.4 Europe Adipose Tissue-derived Stem Cell Therapy Forecast
        10.1.5 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Forecast
    10.2 Americas Adipose Tissue-derived Stem Cell Therapy Forecast by Country (2023-2028)
        10.2.1 United States Adipose Tissue-derived Stem Cell Therapy Market Forecast
        10.2.2 Canada Adipose Tissue-derived Stem Cell Therapy Market Forecast
        10.2.3 Mexico Adipose Tissue-derived Stem Cell Therapy Market Forecast
        10.2.4 Brazil Adipose Tissue-derived Stem Cell Therapy Market Forecast
    10.3 APAC Adipose Tissue-derived Stem Cell Therapy Forecast by Region (2023-2028)
        10.3.1 China Adipose Tissue-derived Stem Cell Therapy Market Forecast
        10.3.2 Japan Adipose Tissue-derived Stem Cell Therapy Market Forecast
        10.3.3 Korea Adipose Tissue-derived Stem Cell Therapy Market Forecast
        10.3.4 Southeast Asia Adipose Tissue-derived Stem Cell Therapy Market Forecast
        10.3.5 India Adipose Tissue-derived Stem Cell Therapy Market Forecast
        10.3.6 Australia Adipose Tissue-derived Stem Cell Therapy Market Forecast
    10.4 Europe Adipose Tissue-derived Stem Cell Therapy Forecast by Country (2023-2028)
        10.4.1 Germany Adipose Tissue-derived Stem Cell Therapy Market Forecast
        10.4.2 France Adipose Tissue-derived Stem Cell Therapy Market Forecast
        10.4.3 UK Adipose Tissue-derived Stem Cell Therapy Market Forecast
        10.4.4 Italy Adipose Tissue-derived Stem Cell Therapy Market Forecast
        10.4.5 Russia Adipose Tissue-derived Stem Cell Therapy Market Forecast
    10.5 Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Forecast by Region (2023-2028)
        10.5.1 Egypt Adipose Tissue-derived Stem Cell Therapy Market Forecast
        10.5.2 South Africa Adipose Tissue-derived Stem Cell Therapy Market Forecast
        10.5.3 Israel Adipose Tissue-derived Stem Cell Therapy Market Forecast
        10.5.4 Turkey Adipose Tissue-derived Stem Cell Therapy Market Forecast
        10.5.5 GCC Countries Adipose Tissue-derived Stem Cell Therapy Market Forecast
    10.6 Global Adipose Tissue-derived Stem Cell Therapy Forecast by Type (2023-2028)
    10.7 Global Adipose Tissue-derived Stem Cell Therapy Forecast by Application (2023-2028)

11 Key Players Analysis
    11.1 AlloCure
        11.1.1 AlloCure Company Information
        11.1.2 AlloCure Adipose Tissue-derived Stem Cell Therapy Product Offered
        11.1.3 AlloCure Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)
        11.1.4 AlloCure Main Business Overview
        11.1.5 AlloCure Latest Developments
    11.2 Antria
        11.2.1 Antria Company Information
        11.2.2 Antria Adipose Tissue-derived Stem Cell Therapy Product Offered
        11.2.3 Antria Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)
        11.2.4 Antria Main Business Overview
        11.2.5 Antria Latest Developments
    11.3 Celgene Corporation
        11.3.1 Celgene Corporation Company Information
        11.3.2 Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Product Offered
        11.3.3 Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)
        11.3.4 Celgene Corporation Main Business Overview
        11.3.5 Celgene Corporation Latest Developments
    11.4 Cellleris
        11.4.1 Cellleris Company Information
        11.4.2 Cellleris Adipose Tissue-derived Stem Cell Therapy Product Offered
        11.4.3 Cellleris Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)
        11.4.4 Cellleris Main Business Overview
        11.4.5 Cellleris Latest Developments
    11.5 Corestem
        11.5.1 Corestem Company Information
        11.5.2 Corestem Adipose Tissue-derived Stem Cell Therapy Product Offered
        11.5.3 Corestem Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)
        11.5.4 Corestem Main Business Overview
        11.5.5 Corestem Latest Developments
    11.6 Cytori Therapeutics
        11.6.1 Cytori Therapeutics Company Information
        11.6.2 Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Offered
        11.6.3 Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)
        11.6.4 Cytori Therapeutics Main Business Overview
        11.6.5 Cytori Therapeutics Latest Developments
    11.7 Intrexon
        11.7.1 Intrexon Company Information
        11.7.2 Intrexon Adipose Tissue-derived Stem Cell Therapy Product Offered
        11.7.3 Intrexon Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)
        11.7.4 Intrexon Main Business Overview
        11.7.5 Intrexon Latest Developments
    11.8 Mesoblast
        11.8.1 Mesoblast Company Information
        11.8.2 Mesoblast Adipose Tissue-derived Stem Cell Therapy Product Offered
        11.8.3 Mesoblast Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)
        11.8.4 Mesoblast Main Business Overview
        11.8.5 Mesoblast Latest Developments
    11.9 Pluristem Therapeutics
        11.9.1 Pluristem Therapeutics Company Information
        11.9.2 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Offered
        11.9.3 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)
        11.9.4 Pluristem Therapeutics Main Business Overview
        11.9.5 Pluristem Therapeutics Latest Developments
    11.10 Tissue Genesis
        11.10.1 Tissue Genesis Company Information
        11.10.2 Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Product Offered
        11.10.3 Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)
        11.10.4 Tissue Genesis Main Business Overview
        11.10.5 Tissue Genesis Latest Developments
    11.11 BioRestorative Therapies
        11.11.1 BioRestorative Therapies Company Information
        11.11.2 BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Product Offered
        11.11.3 BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)
        11.11.4 BioRestorative Therapies Main Business Overview
        11.11.5 BioRestorative Therapies Latest Developments
    11.12 Celltex Therapeutics Corporation
        11.12.1 Celltex Therapeutics Corporation Company Information
        11.12.2 Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Product Offered
        11.12.3 Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)
        11.12.4 Celltex Therapeutics Corporation Main Business Overview
        11.12.5 Celltex Therapeutics Corporation Latest Developments
    11.13 iXCells Biotechnologies
        11.13.1 iXCells Biotechnologies Company Information
        11.13.2 iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Product Offered
        11.13.3 iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)
        11.13.4 iXCells Biotechnologies Main Business Overview
        11.13.5 iXCells Biotechnologies Latest Developments
    11.14 Pluristem Therapeutics
        11.14.1 Pluristem Therapeutics Company Information
        11.14.2 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Offered
        11.14.3 Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)
        11.14.4 Pluristem Therapeutics Main Business Overview
        11.14.5 Pluristem Therapeutics Latest Developments
    11.15 Cyagen
        11.15.1 Cyagen Company Information
        11.15.2 Cyagen Adipose Tissue-derived Stem Cell Therapy Product Offered
        11.15.3 Cyagen Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)
        11.15.4 Cyagen Main Business Overview
        11.15.5 Cyagen Latest Developments
    11.16 Lonza
        11.16.1 Lonza Company Information
        11.16.2 Lonza Adipose Tissue-derived Stem Cell Therapy Product Offered
        11.16.3 Lonza Adipose Tissue-derived Stem Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)
        11.16.4 Lonza Main Business Overview
        11.16.5 Lonza Latest Developments
12 Research Findings and Conclusion

List of Tables
    Table 1. Adipose Tissue-derived Stem Cell Therapy Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
    Table 2. Major Players of Autologous Stem Cells
    Table 3. Major Players of Allogeneic Stem Cells
    Table 4. Adipose Tissue-derived Stem Cell Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
    Table 5. Global Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2017-2022) & ($ Millions)
    Table 6. Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type (2017-2022)
    Table 7. Adipose Tissue-derived Stem Cell Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
    Table 8. Global Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2017-2022) & ($ Millions)
    Table 9. Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application (2017-2022)
    Table 10. Global Adipose Tissue-derived Stem Cell Therapy Revenue by Players (2020-2022) & ($ Millions)
    Table 11. Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Player (2020-2022)
    Table 12. Adipose Tissue-derived Stem Cell Therapy Key Players Head office and Products Offered
    Table 13. Adipose Tissue-derived Stem Cell Therapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 14. New Products and Potential Entrants
    Table 15. Mergers & Acquisitions, Expansion
    Table 16. Global Adipose Tissue-derived Stem Cell Therapy Market Size by Regions 2017-2022 & ($ Millions)
    Table 17. Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Regions (2017-2022)
    Table 18. Americas Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2017-2022) & ($ Millions)
    Table 19. Americas Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Country (2017-2022)
    Table 20. Americas Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2017-2022) & ($ Millions)
    Table 21. Americas Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type (2017-2022)
    Table 22. Americas Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2017-2022) & ($ Millions)
    Table 23. Americas Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application (2017-2022)
    Table 24. APAC Adipose Tissue-derived Stem Cell Therapy Market Size by Region (2017-2022) & ($ Millions)
    Table 25. APAC Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Region (2017-2022)
    Table 26. APAC Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2017-2022) & ($ Millions)
    Table 27. APAC Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type (2017-2022)
    Table 28. APAC Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2017-2022) & ($ Millions)
    Table 29. APAC Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application (2017-2022)
    Table 30. Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Country (2017-2022) & ($ Millions)
    Table 31. Europe Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Country (2017-2022)
    Table 32. Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2017-2022) & ($ Millions)
    Table 33. Europe Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type (2017-2022)
    Table 34. Europe Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2017-2022) & ($ Millions)
    Table 35. Europe Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application (2017-2022)
    Table 36. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Region (2017-2022) & ($ Millions)
    Table 37. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Region (2017-2022)
    Table 38. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Type (2017-2022) & ($ Millions)
    Table 39. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type (2017-2022)
    Table 40. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size by Application (2017-2022) & ($ Millions)
    Table 41. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application (2017-2022)
    Table 42. Key Market Drivers & Growth Opportunities of Adipose Tissue-derived Stem Cell Therapy
    Table 43. Key Market Challenges & Risks of Adipose Tissue-derived Stem Cell Therapy
    Table 44. Key Industry Trends of Adipose Tissue-derived Stem Cell Therapy
    Table 45. Global Adipose Tissue-derived Stem Cell Therapy Market Size Forecast by Regions (2023-2028) & ($ Millions)
    Table 46. Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share Forecast by Regions (2023-2028)
    Table 47. Global Adipose Tissue-derived Stem Cell Therapy Market Size Forecast by Type (2023-2028) & ($ Millions)
    Table 48. Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share Forecast by Type (2023-2028)
    Table 49. Global Adipose Tissue-derived Stem Cell Therapy Market Size Forecast by Application (2023-2028) & ($ Millions)
    Table 50. Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share Forecast by Application (2023-2028)
    Table 51. AlloCure Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors
    Table 52. AlloCure Adipose Tissue-derived Stem Cell Therapy Product Offered
    Table 53. AlloCure Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 54. AlloCure Main Business
    Table 55. AlloCure Latest Developments
    Table 56. Antria Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors
    Table 57. Antria Adipose Tissue-derived Stem Cell Therapy Product Offered
    Table 58. Antria Main Business
    Table 59. Antria Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 60. Antria Latest Developments
    Table 61. Celgene Corporation Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors
    Table 62. Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Product Offered
    Table 63. Celgene Corporation Main Business
    Table 64. Celgene Corporation Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 65. Celgene Corporation Latest Developments
    Table 66. Cellleris Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors
    Table 67. Cellleris Adipose Tissue-derived Stem Cell Therapy Product Offered
    Table 68. Cellleris Main Business
    Table 69. Cellleris Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 70. Cellleris Latest Developments
    Table 71. Corestem Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors
    Table 72. Corestem Adipose Tissue-derived Stem Cell Therapy Product Offered
    Table 73. Corestem Main Business
    Table 74. Corestem Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 75. Corestem Latest Developments
    Table 76. Cytori Therapeutics Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors
    Table 77. Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Offered
    Table 78. Cytori Therapeutics Main Business
    Table 79. Cytori Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 80. Cytori Therapeutics Latest Developments
    Table 81. Intrexon Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors
    Table 82. Intrexon Adipose Tissue-derived Stem Cell Therapy Product Offered
    Table 83. Intrexon Main Business
    Table 84. Intrexon Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 85. Intrexon Latest Developments
    Table 86. Mesoblast Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors
    Table 87. Mesoblast Adipose Tissue-derived Stem Cell Therapy Product Offered
    Table 88. Mesoblast Main Business
    Table 89. Mesoblast Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 90. Mesoblast Latest Developments
    Table 91. Pluristem Therapeutics Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors
    Table 92. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Offered
    Table 93. Pluristem Therapeutics Main Business
    Table 94. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 95. Pluristem Therapeutics Latest Developments
    Table 96. Tissue Genesis Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors
    Table 97. Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Product Offered
    Table 98. Tissue Genesis Main Business
    Table 99. Tissue Genesis Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 100. Tissue Genesis Latest Developments
    Table 101. BioRestorative Therapies Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors
    Table 102. BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Product Offered
    Table 103. BioRestorative Therapies Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 104. BioRestorative Therapies Main Business
    Table 105. BioRestorative Therapies Latest Developments
    Table 106. Celltex Therapeutics Corporation Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors
    Table 107. Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Product Offered
    Table 108. Celltex Therapeutics Corporation Main Business
    Table 109. Celltex Therapeutics Corporation Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 110. Celltex Therapeutics Corporation Latest Developments
    Table 111. iXCells Biotechnologies Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors
    Table 112. iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Product Offered
    Table 113. iXCells Biotechnologies Main Business
    Table 114. iXCells Biotechnologies Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 115. iXCells Biotechnologies Latest Developments
    Table 116. Pluristem Therapeutics Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors
    Table 117. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Product Offered
    Table 118. Pluristem Therapeutics Main Business
    Table 119. Pluristem Therapeutics Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 120. Pluristem Therapeutics Latest Developments
    Table 121. Cyagen Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors
    Table 122. Cyagen Adipose Tissue-derived Stem Cell Therapy Product Offered
    Table 123. Cyagen Main Business
    Table 124. Cyagen Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 125. Cyagen Latest Developments
    Table 126. Lonza Details, Company Type, Adipose Tissue-derived Stem Cell Therapy Area Served and Its Competitors
    Table 127. Lonza Adipose Tissue-derived Stem Cell Therapy Product Offered
    Table 128. Lonza Main Business
    Table 129. Lonza Adipose Tissue-derived Stem Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 130. Lonza Latest Developments
List of Figures
    Figure 1. Adipose Tissue-derived Stem Cell Therapy Report Years Considered
    Figure 2. Research Objectives
    Figure 3. Research Methodology
    Figure 4. Research Process and Data Source
    Figure 5. Global Adipose Tissue-derived Stem Cell Therapy Market Size Growth Rate 2017-2028 ($ Millions)
    Figure 6. Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type in 2021
    Figure 7. Adipose Tissue-derived Stem Cell Therapy in Therapeutic Application
    Figure 8. Global Adipose Tissue-derived Stem Cell Therapy Market: Therapeutic Application (2017-2022) & ($ Millions)
    Figure 9. Adipose Tissue-derived Stem Cell Therapy in Research Application
    Figure 10. Global Adipose Tissue-derived Stem Cell Therapy Market: Research Application (2017-2022) & ($ Millions)
    Figure 11. Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application in 2021
    Figure 12. Global Adipose Tissue-derived Stem Cell Therapy Revenue Market Share by Player in 2021
    Figure 13. Global Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Regions (2017-2022)
    Figure 14. Americas Adipose Tissue-derived Stem Cell Therapy Market Size 2017-2022 ($ Millions)
    Figure 15. APAC Adipose Tissue-derived Stem Cell Therapy Market Size 2017-2022 ($ Millions)
    Figure 16. Europe Adipose Tissue-derived Stem Cell Therapy Market Size 2017-2022 ($ Millions)
    Figure 17. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size 2017-2022 ($ Millions)
    Figure 18. Americas Adipose Tissue-derived Stem Cell Therapy Value Market Share by Country in 2021
    Figure 19. Americas Adipose Tissue-derived Stem Cell Therapy Consumption Market Share by Type in 2021
    Figure 20. Americas Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application in 2021
    Figure 21. United States Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2017-2022 ($ Millions)
    Figure 22. Canada Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2017-2022 ($ Millions)
    Figure 23. Mexico Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2017-2022 ($ Millions)
    Figure 24. Brazil Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2017-2022 ($ Millions)
    Figure 25. APAC Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Region in 2021
    Figure 26. APAC Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application in 2021
    Figure 27. China Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2017-2022 ($ Millions)
    Figure 28. Japan Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2017-2022 ($ Millions)
    Figure 29. Korea Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2017-2022 ($ Millions)
    Figure 30. Southeast Asia Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2017-2022 ($ Millions)
    Figure 31. India Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2017-2022 ($ Millions)
    Figure 32. Australia Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2017-2022 ($ Millions)
    Figure 33. Europe Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Country in 2021
    Figure 34. Europe Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type in 2021
    Figure 35. Europe Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application in 2021
    Figure 36. Germany Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2017-2022 ($ Millions)
    Figure 37. France Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2017-2022 ($ Millions)
    Figure 38. UK Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2017-2022 ($ Millions)
    Figure 39. Italy Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2017-2022 ($ Millions)
    Figure 40. Russia Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2017-2022 ($ Millions)
    Figure 41. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Region in 2021
    Figure 42. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Type in 2021
    Figure 43. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size Market Share by Application in 2021
    Figure 44. Egypt Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2017-2022 ($ Millions)
    Figure 45. South Africa Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2017-2022 ($ Millions)
    Figure 46. Israel Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2017-2022 ($ Millions)
    Figure 47. Turkey Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2017-2022 ($ Millions)
    Figure 48. GCC Country Adipose Tissue-derived Stem Cell Therapy Market Size Growth 2017-2022 ($ Millions)
    Figure 49. Americas Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)
    Figure 50. APAC Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)
    Figure 51. Europe Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)
    Figure 52. Middle East & Africa Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)
    Figure 53. United States Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)
    Figure 54. Canada Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)
    Figure 55. Mexico Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)
    Figure 56. Brazil Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)
    Figure 57. China Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)
    Figure 58. Japan Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)
    Figure 59. Korea Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)
    Figure 60. Southeast Asia Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)
    Figure 61. India Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)
    Figure 62. Australia Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)
    Figure 63. Germany Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)
    Figure 64. France Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)
    Figure 65. UK Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)
    Figure 66. Italy Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)
    Figure 67. Russia Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)
    Figure 68. Spain Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)
    Figure 69. Egypt Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)
    Figure 70. South Africa Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)
    Figure 71. Israel Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)
    Figure 72. Turkey Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)
    Figure 73. GCC Countries Adipose Tissue-derived Stem Cell Therapy Market Size 2023-2028 ($ Millions)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Adipose Tissue-derived Stem Cell Therapy Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Adipose Tissue-derived Stem Cell Therapy Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Adipose Tissue-derived Stem Cell Therapy Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports